Alpa Laboratories Ltd.
NSE: ALPA | BSE: 532878
₹69.16
₹-0.40
(-0.58%)
As on 22-May-2026IST
Market cap
₹147 Cr
Revenue (TTM)
₹114 Cr
P/E Ratio
12.6
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹12 Cr
-
ROE
12.1 %
-
ROCE
15.8 %
-
Industry P/E
30.98
-
EV/EBITDA
8
-
Debt to Equity
0
-
Book Value
₹88
-
EPS
₹5.5
-
Face value
10
-
Shares outstanding
21,040,600
10 Years Aggregate
CFO
₹38.33 Cr
EBITDA
₹61.08 Cr
Net Profit
₹85.24 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Alpa Laboratories
| -11.0 | 0.5 | 3.4 | -35.4 | 5.6 | 4.1 | 7.2 |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Alpa Laboratories
| -37.5 | 14.0 | 64.0 | -20.7 | 117.8 | 120.4 | -34.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Alpa Laboratories
|
69.2 | 146.7 | 114.3 | 11.7 | -2.2 | 6.6 | 12.6 | 0.8 |
| 3,107.5 | 38,804.4 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.7 | 8.6 | |
| 8,587.5 | 21,510.6 | 2,177.5 | 200.9 | 11.3 | 26.5 | 107.1 | 25.9 | |
| 2,028.0 | 15,420.9 | 2,187.2 | 649.7 | 31.5 | 19 | 24 | 4.3 | |
| 1,343.8 | 18,628.3 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.1 | 4.8 | |
| 2,192.6 | 35,263.5 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.7 | 8.5 | |
| 4,670.8 | 21,395.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.6 | 5.1 | |
| 5,553.0 | 9,231.7 | 1,348.5 | 293.5 | 28.1 | 50.7 | 31.5 | 13.2 | |
| 490.3 | 9,644.1 | 1,538.1 | 226.2 | 20.4 | 9 | 39.6 | 3.9 | |
| 1,153.2 | 10,628.0 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Alpa Laboratories
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.
-
Incorporated
1988
-
Chairman
Mahendra Singh Chawla
-
Managing Director
Paresh Chawla
-
Headquarters
Indore Dist, Madhya Pradesh
-
Website
Looking for more details about Alpa Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsClarification Sought from Alpa Laboratories Ltd
08-Apr-2026Board Meeting Outcome for Financial Results
11-Feb-2026No News & Announcements are available.
FAQs for Alpa Laboratories
What is the current share price of Alpa Laboratories Ltd Today?
The share price of Alpa Laboratories Ltd is ₹69.16 (NSE) and ₹69.70 (BSE) as of 22-May-2026 IST. Alpa Laboratories Ltd has given a return of 5.56% in the last 3 years.
What is the current PB & PE ratio of Alpa Laboratories Ltd?
The P/E ratio of Alpa Laboratories Ltd is 12.58 times as on 22-May-2026, a 59 discount to its peers’ median range of 30.98 times.
The P/B ratio of Alpa Laboratories Ltd is 0.79 times as on 22-May-2026, a 83 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
11.23
|
1.28
|
|
2024
|
10.46
|
1.16
|
|
2023
|
8.99
|
0.84
|
|
2022
|
10.38
|
1.20
|
|
2021
|
10.50
|
0.71
|
What is the 52 Week High and Low of Alpa Laboratories Ltd?
The 52-week high and low of Alpa Laboratories Ltd are Rs 120.50 and Rs 46.10 as of 22-May-2026.
What is the market cap of Alpa Laboratories Ltd?
Alpa Laboratories Ltd has a market capitalisation of ₹ 147 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Alpa Laboratories Ltd?
Before investing in Alpa Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.